Return On Equity of Fortress Biotech, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Fortress Biotech, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • Fortress Biotech, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 12%, a 98% decline year-over-year.
  • Fortress Biotech, Inc. annual Return On Equity for 2024 was 559%, a 82% decline from 2023.
  • Fortress Biotech, Inc. annual Return On Equity for 2023 was 3112%.
  • Fortress Biotech, Inc. annual Return On Equity for 2022 was -70%, a 153% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Fortress Biotech, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 12% -642% -98% 01 Jul 2025 30 Sep 2025
Q2 2025 -106% -645% -120% 01 Apr 2025 30 Jun 2025
Q1 2025 -4696% -5388% -779% 01 Jan 2025 31 Mar 2025
Q4 2024 559% -2553% -82% 01 Oct 2024 31 Dec 2024
Q3 2024 654% +1424% 01 Jul 2024 30 Sep 2024
Q2 2024 539% +786% 01 Apr 2024 30 Jun 2024
Q1 2024 691% +807% 01 Jan 2024 31 Mar 2024
Q4 2023 3112% +3183% 01 Oct 2023 31 Dec 2023
Q3 2023 -771% -716% -1312% 01 Jul 2023 30 Sep 2023
Q2 2023 -247% -201% -438% 01 Apr 2023 30 Jun 2023
Q1 2023 -116% -83% -256% 01 Jan 2023 31 Mar 2023
Q4 2022 -70% -42% -153% 01 Oct 2022 31 Dec 2022
Q3 2022 -55% -38% -220% 01 Jul 2022 30 Sep 2022
Q2 2022 -46% -31% -199% 01 Apr 2022 30 Jun 2022
Q1 2022 -33% -9.1% -39% 01 Jan 2022 31 Mar 2022
Q4 2021 -28% +5.1% +16% 01 Oct 2021 31 Dec 2021
Q3 2021 -17% +34% +67% 01 Jul 2021 30 Sep 2021
Q2 2021 -15% +48% +76% 01 Apr 2021 30 Jun 2021
Q1 2021 -23% +45% +66% 01 Jan 2021 31 Mar 2021
Q4 2020 -33% +23% +41% 01 Oct 2020 31 Dec 2020
Q3 2020 -51% +32% +39% 01 Jul 2020 30 Sep 2020
Q2 2020 -64% +23% +27% 01 Apr 2020 30 Jun 2020
Q1 2020 -69% +30% +30% 01 Jan 2020 31 Mar 2020
Q4 2019 -55% +54% +49% 01 Oct 2019 31 Dec 2019
Q3 2019 -84% -16% -23% 01 Jul 2019 30 Sep 2019
Q2 2019 -87% -15% -21% 01 Apr 2019 30 Jun 2019
Q1 2019 -98% -38% -62% 01 Jan 2019 31 Mar 2019
Q4 2018 -109% -58% -112% 01 Oct 2018 31 Dec 2018
Q3 2018 -68% -6.7% -11% 01 Jul 2018 30 Sep 2018
Q2 2018 -72% -17% -31% 01 Apr 2018 30 Jun 2018
Q1 2018 -61% +3.4% +5.3% 01 Jan 2018 31 Mar 2018
Q4 2017 -52% +25% +33% 01 Oct 2017 31 Dec 2017
Q3 2017 -61% +7.5% +11% 01 Jul 2017 30 Sep 2017
Q2 2017 -55% +27% +33% 01 Apr 2017 30 Jun 2017
Q1 2017 -64% +9.1% +12% 01 Jan 2017 31 Mar 2017
Q4 2016 -77% -0.71% -0.93% 01 Oct 2016 31 Dec 2016
Q3 2016 -69% -2.4% -3.5% 01 Jul 2016 30 Sep 2016
Q2 2016 -82% 01 Apr 2016 30 Jun 2016
Q1 2016 -73% 01 Jan 2016 31 Mar 2016
Q4 2015 -76% 01 Oct 2015 31 Dec 2015
Q3 2015 -67% 01 Jul 2015 30 Sep 2015

Fortress Biotech, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 559% -2553% -82% 01 Jan 2024 31 Dec 2024
2023 3112% +3183% 01 Jan 2023 31 Dec 2023
2022 -70% -42% -153% 01 Jan 2022 31 Dec 2022
2021 -28% +5.1% +16% 01 Jan 2021 31 Dec 2021
2020 -33% +23% +41% 01 Jan 2020 31 Dec 2020
2019 -55% +54% +49% 01 Jan 2019 31 Dec 2019
2018 -109% -58% -112% 01 Jan 2018 31 Dec 2018
2017 -52% +25% +33% 01 Jan 2017 31 Dec 2017
2016 -77% -0.71% -0.93% 01 Jan 2016 31 Dec 2016
2015 -76% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.